跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAVIG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SITAVIG
Authorized
STANDARD
SITAVIG
EPI Health, LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6facdd62d784a42f
Company
EPI Health, LLC
Type
Standard
Approval Details
Approval Id
6facdd62d784a42f
Drug Approval Canada Name
SITAVIG
Product Name
SITAVIG
Status
Approved
Status Date
2020-03-31
Din
02470098
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Buccal
Schedule
Prescription
Ahfs
84:04.06
Atc Original
J05AB01 ACYCLOVIR
Atc Name
j 05 ab 01
Aig Number
0115506009
Company Name
EPI Health, LLC
Company Address
200, 174 Meeting Street, Charleston, South Carolina, United States, 29401
Company Detail Path
/organization/epi-health-llc-charleston-south-carolina-united-states
Company Information
Pharmaceutical Company Name
EPI Health, LLC
Country Name
United States
Province Name
South Carolina
City Name
charleston,south carolina,country_us
Address
276 E Bay St
Active Ingredients
ACYCLOVIR
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6facdd62d784a42f
Type
Standard
Back to Health Canada Approvals